The biotech startup secured its Series B round, which was led by Drive Capital with participation from Chiesi Farmaceutici, GreenSky Capital and members of Cyclica’s management team. (VentureBeat)
Skip to content
The biotech startup secured its Series B round, which was led by Drive Capital with participation from Chiesi Farmaceutici, GreenSky Capital and members of Cyclica’s management team. (VentureBeat)
Talking point: Cyclica’s drug-discovery platform leverages artificial intelligence in the biophysics space. According to the U.S. Food and Drug Administration, a new drug takes an average of 12 to 15 years and over US$2.6 billion dollars to develop—a process Cyclica hopes to decentralize by partnering with other companies and research institutions. With the support of the Ontario Centres of Excellence and IBM, the company has recently harnessed the power of supercomputers to map out a database that will help researchers identify genetic variants. The new funds will be used to forge new partnerships as well as expand its application within the pharma industry and adjacent sectors, such as agro-chemicals.
Loading...
Thanks for sharing!
You have shared 5 articles this month and reached the maximum amount of shares available.
CloseThis account has reached its share limit.
If you would like to purchase a sharing license please contact The Logic support at [email protected].
CloseGift the full article!
You have gifted 0 article(s) this month and have 5 remaining.
Recipients will be able to read the full text of the article after submitting their email address. They will not have access to other articles or subscriber benefits.
Most Popular This Week
In-depth, agenda-setting reporting
Great journalism delivered straight to your inbox.
Commentary
Carmichael: Being boxed in will help Canada focus on what matters
Briefing
Rio Tinto gets nearly $165M in additional federal funds for Quebec aluminum
U.S. to lift tariffs on some Canadian products crucial to Maine: Collins
Carney warns of tech dependence after Starlink disruptions in Ukraine
Best business newsletter in Canada
Get up to speed in minutes with insights and analysis on the most important stories of the day, every weekday.
Exclusive events
See the bigger picture with reporters and industry experts in subscriber-exclusive events.
Membership in The Logic Council
Membership provides access to our popular Slack channel, participation in subscriber surveys and invitations to exclusive events with our journalists and special guests.
